Moffitt Cancer Center Chief BioEngineering Officer, @MoffittNews. Cancer Engineer, Tribologist, Survivor, and Chair of #BioEngineering. Views are my own.
Joined May 2024
- Tweets 861
- Following 203
- Followers 456
- Likes 3,132
77 Photos and videos
Pinned Tweet
May 31
Great chat with @PatrickHwuMD at #ASCO26!
May 31
Live from #ASCO26, I spoke with Dr. Greg Sawyer (@ProfGregSawyer), Chair of Bioengineering @MoffittNews, about the latest in cancer engineering, novel research models and precision medicine.
It’s exciting to see how engineering is helping drive new ideas in cancer therapeutics and improve the way scientists study cancer. #ASCO26 #MoffittASCO26
1
5
276
W. Gregory Sawyer retweeted
3
9
970
W. Gregory Sawyer retweeted
Jun 11
Can a #probiotic really “fix” your gut?
In the latest episode of The ImmunoVerse, I sit down with Dr. Jennifer Wargo (@JenWargoMD) of @UTMDAnderson to explore what science is teaching us about the microbiome, cancer and immunotherapy.
We discuss how gut bacteria may shape treatment response, why fiber helps feed the right microbes and why over-the-counter probiotics may not always be the answer.
Listen today at Moffitt.org/ImmunoVerse or any major podcast platform.
#TheImmunoVerse #Microbiome #Immunotherapy #GutHealth @MoffittNews
5
9
1,109
W. Gregory Sawyer retweeted
11
25
1,971
Honored to join fellow innovators and researchers at the @AcadofInventors Annual Conference and Inaugural Fellows Celebration.
The conference showcased the power of research and innovation to improve lives and tackle complex challenges. It was a privilege to represent @MoffittNews and celebrate the discoveries and collaborations that are shaping the future of cancer care.
Congratulations to the newest class of NAI Fellows! #NAI2026
5
12
692
Proud to represent @MoffittNews at #NAI2026!
Congratulations to Greg Sawyer, PhD, on being recognized as a Charter Fellow by the National Academy of Inventors!
This recognition reflects his commitment to fostering innovation to transform cancer research.
With eight @AcadofInventors Fellows, Moffitt Cancer Center continues to be recognized as a leader in cutting-edge research and discoveries.
Our Fellows include:
• Patrick Hwu, MD (@PatrickHwuMD)
• William Dalton, PhD, MD
• Steven Eschrich, PhD
• Nicholas Lawerence, PhD
• G. Letson, MD
• David Morse, PhD
• James Mule, IPhD (@DrJamesMule)
• Greg Sawyer, PhD (@ProfGregSawyer)
Together, their discoveries are helping advance our mission to prevent and cure cancer.
#NAI2026
4
183
Happy birthday @PatrickHwuMD!
Wishing our President and CEO @PatrickHwuMD a very happy birthday! 🥳
1
111
W. Gregory Sawyer retweeted
From groundbreaking research to practice-changing data, #ASCO26 highlighted the progress being made across the cancer continuum.
Moffitt experts were proud to join nearly 50,000 oncology professionals from around the world to share research and help drive progress for patients.
Explore Moffitt's meeting highlights at moffitt.org/ASCO.
See you in Chicago for #ASCO27!
#MoffittASCO26
13
20
1,222
W. Gregory Sawyer retweeted
8
12
1,404
W. Gregory Sawyer retweeted
8
9
682
W. Gregory Sawyer retweeted
7
10
410
W. Gregory Sawyer retweeted
2
6
7
521
W. Gregory Sawyer retweeted
Jun 2
Another incredible @ASCO Annual Meeting in the books. 🌟
An inspiring few day with the @MoffittNews team, sharing research, connecting with colleagues and celebrating the progress being made for patients everywhere.
Until next time, Chicago!
#ASCO26 #MoffittASCO26
6
28
1,293
W. Gregory Sawyer retweeted
7
9
486
W. Gregory Sawyer retweeted
5
12
538
W. Gregory Sawyer retweeted
5
6
321
W. Gregory Sawyer retweeted
At #ASCO26, Karen Lu, MD (@karenluMD), joins @PatrickHwuMD to discuss Moffitt’s strong presence at the annual meeting and the innovations driving the future of cancer care.
From advances in targeted therapies and immunotherapy to leadership in digital pathology and rare cancer diagnosis, they highlight how Moffitt continues to help shape the next generation of oncology breakthroughs. #MoffittASCO26
12
19
1,265
W. Gregory Sawyer retweeted
During #ASCO26, Hatem Soliman, MD, shares research exploring a personalized dendritic cell vaccine approach for high-risk triple-negative breast cancer, highlighting precision medicine strategies designed to help prevent recurrence. #MoffittASCO26
6
15
1,264
W. Gregory Sawyer retweeted
‼️New findings from the SARC041 trial presented at #ASCO26 suggest abemaciclib significantly improved progression-free survival in patients with advanced dedifferentiated liposarcoma, supporting its potential as a new treatment option for this rare sarcoma subtype.
Moffitt’s Mihaela Druta, MD (@MihaelaDruta), stopped by the booth to discuss the data from Mark Dickson, MD, of @MSKCancerCenter, highlighting the promise of a new therapy for patients with recurrent or metastatic dedifferentiated liposarcoma. #MoffittASCO26
8
24
1,297
W. Gregory Sawyer retweeted
Live from #ASCO26: Kedar Kirtane, MD (@DrKedarKirtane), discusses emerging cell therapies in head and neck cancer and advances helping shape the future of treatment.
Key takeaways:
• Head and neck cancers are uniquely positions to respond to immune modulation.
• TILs, TCRs, and CAR-T represent the most common cell therapy approaches—thus far with modest results.
• New advancements in these arenas will hopefully improve overall survival and quality of life.
#MoffittASCO26
6
10
619
W. Gregory Sawyer retweeted
3
7
20
308,834